Skip to main content
Gentian Diagnostics ASA logo

Gentian Diagnostics ASA — Investor Relations & Filings

Ticker · GENT ISIN · NO0010748866 LEI · 5967007LIEEXZXHNM861 OL Manufacturing
Filings indexed 466 across all filing types
Latest filing 2025-04-07 Director's Dealing
Country NO Norway
Listing OL GENT

About Gentian Diagnostics ASA

https://www.gentian.com/

Gentian Diagnostics ASA is a medical diagnostics company that develops, manufactures, and markets innovative in vitro diagnostic (IVD) reagents. The company specializes in turbidimetric immunoassays designed for open clinical chemistry platforms, aiming to enhance laboratory efficiency and support better clinical treatment decisions. Its portfolio and pipeline of diagnostic tests address biomarkers in high-impact medical areas, including kidney disease, cardiac disease, inflammation, and infection. Key products include assays for Cystatin C, NGAL, and Calprotectin. In addition to its human diagnostics portfolio, the company provides diagnostic solutions for the veterinary market. Gentian serves a global customer base through original equipment manufacturer (OEM) partners, distributors, and healthcare providers.

Recent filings

Filing Released Lang Actions
Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document text explicitly uses the template title: 'KRT-1500 Template for notification of transactions by persons discharging managerial responsibilities (PDMR) and persons closely associated with them'. It details a transaction (Acquisition) by a Board member (KJERSTI GRIMSRUD) involving shares, including price, volume, and date. This content directly corresponds to the definition of Director's Dealing (insider trades by executives/directors).
2025-04-07 English
Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document is titled 'Mandatory notification of trade' and explicitly states that a transaction was completed by a 'close associate of a primary insider' (a board member). It mentions the purchase of shares and refers to a 'PCA notification pursuant to the EU Market Abuse Regulation Article 19'. This content directly corresponds to the reporting of personal share transactions by company directors and executives, which aligns perfectly with the definition for Director's Dealing (DIRS). The document length is very short (796 chars), but the content is a direct notification of insider trading, not just an announcement of a report, making DIRS the most specific fit over RNS or RPA.
2025-04-07 English
Gentian Diagnostics strengthens commercial capabilities with key appointments
Board/Management Information Classification · 99% confidence The document is a press release dated March 28, 2025, announcing two strategic appointments: Markus Jaquemar as Chief Growth Officer and Hanne Kjellevold Kristiansen as Vice President, Commercial. This content directly relates to changes in senior management personnel within the company. According to the definitions, this aligns perfectly with the 'Board/Management Information' category.
2025-03-28 English
Correction: Gentian Diagnostics: Annual report 2024
Annual Report (ESEF) Classification · 100% confidence FY 2024
2025-03-21 English
Correction: Gentian Diagnostics: Annual report 2024
Annual Report Classification · 100% confidence The document is titled 'Annual report' and contains comprehensive sections including a letter from the CEO, key financial figures for 2024, board of directors report, corporate governance, ESG report, and financial statements. It covers the full fiscal year 2024 and provides detailed business analysis and financial performance data, which aligns perfectly with the definition of an Annual Report (10-K). FY 2024
2025-03-21 English
Correction: Gentian Diagnostics: Annual report 2024
Report Publication Announcement Classification · 100% confidence The document is a short announcement (622 characters) stating that the 2024 Annual Report has been published and is attached to the notice. Per the 'Menu vs Meal' rule, an announcement stating that a report is attached or available for download is classified as a Report Publication Announcement (RPA), not the report itself. FY 2024
2025-03-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.